Clinical Trials Browser

Diabetes Mellitus, Insulin-Dependent, 12, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Melanoma, Mesothelioma, Stomach Neoplasms, Endometrial Neoplasms

NCT05207787 2023-06-01

Phase Ⅰ/Ⅱ Study of the HS-10365 in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

306 enrolled

Other solid neoplasm

Solid Tumor

NCT05862831 2023-05-17

Clinical Study of PM1003 in Phase I/IIa Treatment of Advanced Malignant Solid Tumors

Phase 1/2 Unknown

285 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05833984 2023-04-27

Safety and Efficacy of IMM01 Plus Tislelizumab in Patients With Advanced Solid Tumors and Lymphomas

Phase 1/2 Unknown

309 enrolled

LymphoidOther solid neoplasm

Solid Tumor

NCT04571892 2023-04-12

A Clinical Study to Observe the Safety and Efficacy of ScTIL210 in the Treatment of Malignant Solid Tumors

Phase 1/2 Unknown

58 enrolled

Other solid neoplasm

Malignant Solid Tumor

NCT05805956 2023-04-10

IMM2902 in Patients With Advanced Solid Tumors Expressing HER2

Phase 1/2 Unknown

105 enrolled

GastrointestinalOther solid neoplasmThoracic

Advanced Solid Tumor

NCT05434299 2023-03-16

A Study of TFX05-01 in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

36 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT03475953 2023-03-03

REGOMUNE

Phase 1/2 Unknown

747 enrolled

BreastEndocrineGastrointestinalGenitourinaryHead & NeckNETOther solid neoplasmSarcomaThoracic

Gastro-enteropancreatic neuroendocrine tumor, Turcot syndrome, Tertiary Lymphoid Structures, Mesothelioma, Malignant, Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Neoplasm Metastasis, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Triple Negative Breast Neoplasms

NCT05748938 2023-03-01

A Study of RD14-01 in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

12 enrolled

Other solid neoplasm

Solid Tumor

NCT05740215 2023-02-22

Efficacy and Safety Study of F520 Combined With Lenvatinib in the Treatment of Patients With Advanced Solid Tumors

Phase 1/2 Unknown

158 enrolled

Other solid neoplasm

Solid Tumors

NCT05688605 2023-01-18

A Study of MRG003 in the Treatment of Patients With EGFR-positive Advanced or Metastatic Solid Tumors

Phase 1/2 Unknown

18 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05645315 2022-12-09

Clinical Trial of TQB2618 Injection Combined With TQB2450 Injection in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

127 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT04450901 2022-12-05

Dose Escalation/Dose Expansion Study of YBL-006 in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

90 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05338957 2022-12-01

A Study of MRG002 in the Treatment of Patients With HER2-expressed Advanced Malignant Solid Tumors.

Phase 1/2 Unknown

30 enrolled

Other solid neoplasm

Advanced Malignant Solid Tumors

NCT04765462 2022-10-04

Allogeneic γδ T Cell Therapy for the Treatment of Solid Tumors

Phase 1/2 Unknown

60 enrolled

Other solid neoplasm

Malignant Solid Tumours

NCT05457517 2022-09-27

A Phase 1b/2 Study of YL-13027 Combined With Sintilimab in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

49 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT04843709 2022-09-08

A Study of MRG004A in Patients With Tissue Factor Positive Advanced or Metastatic Solid Tumors

Phase 1/2 Unknown

181 enrolled

Other solid neoplasm

Advanced or Metastatic Solid Tumors

NCT05524194 2022-09-01

6MW3511 in Patients With Advanced Solid Tumor

Phase 1/2 Unknown

272 enrolled

Other solid neoplasm

Solid Tumors

NCT05332574 2022-08-05

A Safety, Tolerability, PK and Preliminary Activity Study of GB263T in Advanced NSCLC and Other Solid Tumor

Phase 1/2 Unknown

120 enrolled

Other solid neoplasmThoracic

NSCLC

NCT05478785 2022-07-29

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Efficacy of Cisplatin Micelle Injection (HA132) in Patients With Advanced Malignant Solid Tumors

Phase 1/2 Unknown

126 enrolled

Other solid neoplasm

Advanced Malignant Solid Tumors

NCT05425602 2022-06-21

A Study of MAX-40279combined With KN046 in Patients With Advanced / Metastatic Solid Tumors

Phase 1/2 Unknown

108 enrolled

Other solid neoplasm

Advanced / Metastatic Solid Tumors

NCT05258266 2022-03-14

A Study to Evaluate the Activity, Safety and Tolerability of ZX-101A in Advanced Solid Tumors

Phase 1/2 Unknown

76 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT05119933 2021-11-15

A Phase 1/2, Study of YL-15293 in Subjects With Advanced Solid Tumors With a KRAS G12C Mutation

Phase 1/2 Unknown

55 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT04937842 2021-06-24

Microtransplantation for Advanced and Relapsed Solid Tumors

Phase 1/2 Unknown

60 enrolled

Other solid neoplasm

Solid Tumors

NCT04699643 2021-01-07

FGFR4 Inhibitor EVER4010001 in Combination With PD-1 Inhibitor Pembrolizumab in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

80 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT04226066 2020-12-07

Safety, Tolerability and Pharmacokinetics Characteristics of Recombinant Oncolytic Vaccinia Virus Injection T601 as a Single Drug or in Combination With Oral Flucytosine (5-FC), in Patients With Advanced Malignant Solid Tumors

Phase 1/2 Unknown

69 enrolled

Other solid neoplasm

Advanced Malignant Solid Tumors

NCT04432649 2020-06-16

Targeting CD276 (B7-H3) Positive Solid Tumors by 4SCAR-276

Phase 1/2 Unknown

100 enrolled

Other solid neoplasm

Solid Tumor

NCT03160833 2020-02-13

A Study of HMPL-453 in Patients With Advanced Solid Malignancies

Phase 1/2 Unknown

33 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT03638206 2019-12-11

Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies

Phase 1/2 Unknown

73 enrolled

CNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidOther hematologic neoplasmOther solid neoplasmPlasma cellSarcomaThoracic

Burkitt Lymphoma, Carcinoma, Renal Cell, Esophageal Neoplasms, Glioma, Carcinoma, Hepatocellular, Leukemia, Myeloid, Lung Neoplasms, Lymphoma, Melanoma, Mesothelioma, Multiple Myeloma, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Sarcoma, Synovial, Colorectal Neoplasms

NCT04151329 2019-11-05

A Phase I Clinical Trial of BAT1306 and BAT8001 Injection in Patients With Solid Tumor

Phase 1/2 Unknown

72 enrolled

Other solid neoplasm

Solid Tumor

NCT04143789 2019-10-31

Evaluation of AP-002 in Patients With Solid Tumors

Phase 1/2 Unknown

61 enrolled

Other solid neoplasm

Solid Tumor

NCT03628131 2018-09-19

Combination Chemotherapy With Pazopanib in Children and Adolescents With Relapsed/Refractory Solid Tumors

Phase 1/2 Unknown

46 enrolled

Other solid neoplasm

Relapsed Pediatric Solid Tumor

Clinical Trials

Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid Tumors

A Phase Ib/II Study of GT90001 Combined With KN046 in Solid Tumors

A Study of ZG19018 in Patients With KRAS G12C Mutant Advanced Solid Tumors.

Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma

Safety and Efficacy of RX-af01 Combined With PD-1 Antibody

KD6001 in Combination With Anti-PD-1 Antibody±Bevacizumab in Patients With Advanced HCC and Other Solid Tumors

A Phase IB/II Clinical Study of SHR-A2009 for Injection in Combination With Other Antitumor Therapies in Patients With Advanced Solid Tumors

A Study to Observe and Evaluate the Safety and Efficacy of T60c Injection for Treatment of Advanced Solid Tumor Patients

A Study to Observe and Evaluate the Safety and Efficacy of c610 Injection for Treatment of Advanced Solid Tumor Patients

A Phase 1/2 Study of 7MW3711 in Advanced Solid Tumors

A Study of 7MW3711 in Subjects With Advanced Solid Tumors

IMMINENT-01

A Clinical Trial to Evaluate the Effect of IAE0972 in Patients With Advanced Malignant Solid Tumors.

Phase I Clinical Study of YL-15293 in Patients With Advanced Solid Tumor With KRAS Mutation

Phase I/II Study of αPD1-MSLN-CAR T Cells in MSLN-positive Advanced Solid Tumors

ALG.APV-527 First-in-human Study

BPB-101 in Subjects With Metastatic or Locally Advanced Solid Tumors

A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors

ICEMELT

Phase Ⅰ/Ⅱ Study of the HS-10365 in Patients With Advanced Solid Tumors

Clinical Study of PM1003 in Phase I/IIa Treatment of Advanced Malignant Solid Tumors

Safety and Efficacy of IMM01 Plus Tislelizumab in Patients With Advanced Solid Tumors and Lymphomas

A Clinical Study to Observe the Safety and Efficacy of ScTIL210 in the Treatment of Malignant Solid Tumors

IMM2902 in Patients With Advanced Solid Tumors Expressing HER2

A Study of TFX05-01 in Patients With Advanced Solid Tumors

REGOMUNE

A Study of RD14-01 in Patients With Advanced Solid Tumors

Efficacy and Safety Study of F520 Combined With Lenvatinib in the Treatment of Patients With Advanced Solid Tumors

A Study of MRG003 in the Treatment of Patients With EGFR-positive Advanced or Metastatic Solid Tumors

Clinical Trial of TQB2618 Injection Combined With TQB2450 Injection in Patients With Advanced Solid Tumors

Dose Escalation/Dose Expansion Study of YBL-006 in Patients With Advanced Solid Tumors

A Study of MRG002 in the Treatment of Patients With HER2-expressed Advanced Malignant Solid Tumors.

Allogeneic γδ T Cell Therapy for the Treatment of Solid Tumors

A Phase 1b/2 Study of YL-13027 Combined With Sintilimab in Patients With Advanced Solid Tumors

A Study of MRG004A in Patients With Tissue Factor Positive Advanced or Metastatic Solid Tumors

6MW3511 in Patients With Advanced Solid Tumor

A Safety, Tolerability, PK and Preliminary Activity Study of GB263T in Advanced NSCLC and Other Solid Tumor

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Efficacy of Cisplatin Micelle Injection (HA132) in Patients With Advanced Malignant Solid Tumors

A Study of MAX-40279combined With KN046 in Patients With Advanced / Metastatic Solid Tumors

A Study to Evaluate the Activity, Safety and Tolerability of ZX-101A in Advanced Solid Tumors

A Phase 1/2, Study of YL-15293 in Subjects With Advanced Solid Tumors With a KRAS G12C Mutation

Microtransplantation for Advanced and Relapsed Solid Tumors

FGFR4 Inhibitor EVER4010001 in Combination With PD-1 Inhibitor Pembrolizumab in Patients With Advanced Solid Tumors

Safety, Tolerability and Pharmacokinetics Characteristics of Recombinant Oncolytic Vaccinia Virus Injection T601 as a Single Drug or in Combination With Oral Flucytosine (5-FC), in Patients With Advanced Malignant Solid Tumors

Targeting CD276 (B7-H3) Positive Solid Tumors by 4SCAR-276

A Study of HMPL-453 in Patients With Advanced Solid Malignancies

Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies

A Phase I Clinical Trial of BAT1306 and BAT8001 Injection in Patients With Solid Tumor

Evaluation of AP-002 in Patients With Solid Tumors

Combination Chemotherapy With Pazopanib in Children and Adolescents With Relapsed/Refractory Solid Tumors